About ViaGen
ViaGen is a company based in Austin (United States) founded in 2002 was acquired by Trans Ova Genetics in June 2012. ViaGen operates in a competitive market with competitors including Biocytogen, Interius Biotherapeutics, Vytelle, Applied StemCell and Hendrix Genetics, among others.
- Headquarter Austin, United States
-
Sectors
HealthcareAgriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$149.96 K (USD), Grant
Jan 01, 2011
-
Investors
Trans Ova Genetics
& 1 more
-
Employee Count
Not available
-
Acquired by
Trans Ova Genetics
(Jun 01, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ViaGen
Investors in ViaGen
ViaGen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Trans Ova Genetics and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked | |
|
Reproduction and breeding services for livestock genetics are provided.
|
Locked | Locked | Locked |
Investor details for ViaGen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ViaGen
Investment portfolio details for ViaGen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ViaGen
Detailed financials for ViaGen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Viagen Comparisons
Peer comparison for ViaGen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ViaGen
ViaGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Interius Biotherapeutics, Vytelle, Applied StemCell and Hendrix Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating multiple diseases
|
|
| Locked | Locked | Locked |
Provider of genetic breeding services for livestock producers
|
|
| Locked | Locked | Locked |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| Locked | Locked | Locked |
Hybrid animal varieties are developed through marker-assisted breeding methods.
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
Detailed competitors of ViaGen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Viagen
Complete news archive for ViaGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ViaGen
ViaGen was founded in 2002 and raised its 1st funding round 9 years after it was founded.
ViaGen is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Viagen was founded in 2002 in Austin, United States, as a biotechnology firm focused on animal cloning. Genetic preservation solutions, express tissue banking, and cloning services for livestock and pet animals are provided. Genetically superior animals from herds are utilized in the cloning process. Operations center on advancing reproductive technologies within the agricultural and veterinary sectors.
ViaGen's top competitors include Biocytogen, Applied StemCell and Vytelle.
ViaGen has 2 investors. Key investors include Trans Ova Genetics, and National Science Foundation.